0
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Effectiveness of staged excisions for treating lentiginous melanoma in situ

, , &
Pages 549-555 | Published online: 10 Jan 2014

References

  • Brown CD, Zitelli JA. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol. Surg.21(4), 285–290 (1995).
  • American Cancer Society. Cancer Facts and Figures 1997–2008. New York, NY, USA.
  • Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subytpes: northern California and national trends 1990–2000. J. Invest. Dermatol.125, 685–691 (2005).
  • Hutchinson J. Senile freckles. Arch. Surg.3, 319–322 (1892).
  • Hutchinson J. Notes on the cancerous process and on new growths in general. Arch. Surg.2, 83–86 (1890).
  • Hutchinson J. Lentigo-melanosis: a further report. Arch. Surg.5, 253–256 (1894).
  • McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol. Surg.32, 493–504 (2006).
  • Mahoney EJ, Dolan RW, Choi EE, Olbricht SM. Surgical reconstruction of lentigo maligna defects.Arch. Facial Plast. Surg.7, 342–346 (2005).
  • Cohen LM. Lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol.33(6), 923–936 (1995).
  • Johnson TM, Headington JT, Baker SR, Lowe L. Usefullness of the staged excision for lentigo maligna and lentigo maligna melanoma: the ‘square’ procedure. J. Am. Acad. Dermatol.37(5), 758–764 (1997).
  • Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br. J. Dermatol.116, 303–310 (1987).
  • Jackson R, Williamson G, Beattie W. Lentigo maligna and lentigo maligna melanoma. Can. Med. Assoc. J.95, 846–851 (1966).
  • Davis J, Pack GT, Higgins G. Melanotic freckle of Hutchinson. Am. J. Surg.113, 457–463 (1967).
  • Blodi FC, Widner RR. The melanotic freckle (Hutchinson) of the lids. Surv. Ophthalmol.13, 23–30 (1968).
  • Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J. Am. Acad. Dermatol.31(1), 75–78 (1994).
  • Graham GF. Advances in cryosurgery during the past decade. Cutis52(6), 365–372 (1993).
  • Bohler-Sommeregger K, Schuller-Petrovic S, Neumann R, Muller E. Cryosurgery of lentigo maligna. Plast. Reconstr. Surg.90(3), 436–440 (1992).
  • Zalaudek I, Horn M, Richtig E, Hodl S, Kerl H, Smolle J. Local recurrence in melanoma in situ: influence of sex, age, site of involvement and therapeutic modalities. Br. J. Dermatol.148, 703–708 (2003).
  • Cotter MA, McKenna JK, Bowen GM. Treatment of lentigo maligna with imiquimod before staged excision. Dermatol. Surg.34(2), 147–151 (2008).
  • Handley WS. The pathology of melanotic growths in relation to their operative treatment. Lancet1, 927(33), 996–1003 (1907).
  • Veronesi U, Cascinelli N. Narrow excision (1 cm margin): a safe procedure for thin cutaneous melanoma. Arch. Surg.126, 438–441 (1991).
  • Balch CM, Urist MM, Karakousis CP et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm): results of a mulit-institutional randomized surgical trial. Ann. Surg.218, 262–269 (1993).
  • Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma. Ann. Surg. Oncol.3, 446–452 (1996).
  • Cohn-Cedermark G, Rutqvist LE, Andersson R et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer89, 1495–1501 (2000).
  • Khayat D, Rixe O, Martin G. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1 mm thick). Cancer97, 1941–1946 (2003).
  • National Institutes of Health Consensus Conference. Diagnosis and treatment of early melanoma. JAMA268, 1314–1319 (1992).
  • Pitman GH, Kopf AW, Bart RS et al. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol.5, 727–737 (1959).
  • Coleman WP, Davis RS, Reed RJ et al. Treatment of lentigo maligna and lentigo maligna melanoma. J. Dermatol. Surg. Oncol.6, 476–479 (1980).
  • Osborne JE, Hutchinson PE. A follow-up study to investigate the efficacy of initial treatment of lentigo maligna with surgical excision. Br. J. Plast. Surg.55, 611–615 (2002).
  • Temple CLF, Arlette JP. Mohs micrographic surgery in the treatment of lentigo maligna and melanoma. J. Surg. Oncol.94(4), 287–292 (2006).
  • Ziteli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J. Am. Acad. Dermatol.37, 236–245 (1997).
  • Cohen LM, McCall MW, Zax RH. Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. Dermatol. Surg.24(6), 673–677 (1998).
  • Dhawan S, Wolf D, Rabinowitz H, Poulos E. Lentigo maligna – the use of rush permanent sections in therapy. Arch. Dermatol.126, 928–930 (1990).
  • Huilgol S, Selva D, Chen C et al. Surgical margins for lentigo maligna and lentigo maligna melanoma- the technique of mapped serial excision. Arch. Dermatol.140, 1087–1092 (2004).
  • Agarwal-Antan N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J. Am. Acad. Dermatol.47(5), 743–748 (2002).
  • Hill DC, Gramp AA. Surgical treatment of lentigo maligna and lentigo maligna melanoma. Aust. J. Dermatol.40, 25–30 (1999).
  • Wayte DM, Helwig EB. Melanotic freckle of Hutchinson. Cancer21, 893–911 (1968).
  • Malhotra R, Chen C, Huilgol SC, Hill DC, Selva D. Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma. Ophthalmology110(10), 2011–2018 (2003).
  • Bub JL, Berg D, Slee A, Odland PB. Management of lentigo maligna and lentigo maligna melanoma with staged excision. Arch. Dermatol.140, 552–558 (2004).
  • Huilgol S, Selva D, Chen C et al. Surgical margins for lentigo maligna and lentigo maligna melanoma- the technique of mapped serial excision. Arch. Dermatol.140, 1087–1092 (2004).
  • Jejurikar SS, Borschel GH, Johnson TM, Lowe L, Brown DL. Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast. Reconstr. Surg.120, 1249–1255 (2007).
  • Charles CA, Yee VS, Dusza SW et al. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists. Arch. Dermatol.141, 723–729 (2005).
  • Walling HW, Scupham RK, Bean AK, Ceilley RI et al. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma. J. Am. Acad. Dermatol.57, 659–664 (2007).
  • Hazan C, Dusza SW, Delgado R, Busam KJ, Halpern AC, Nehal KS. Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases. J. Am. Acad. Dermatol.58(1), 142–148 (2008).
  • Florell SR, Boucher KM, Leachman SA et al. Histopathologic recognition of involved margins of lentigo maligna excised by staged excision: an interobserver comparison study. Arch. Dermatol.139(5), 595–604 (2003).
  • Hendi A, Brodland DG, Zitelli JA. Melanocytes in long affiliations-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch. Dermatol.142(7), 871–876 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.